Whan In Pharm Co.,Ltd. (KRX:016580)
11,900
-80 (-0.67%)
Last updated: Jun 23, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Pharmaceutical | 259.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Psychotropic Drug | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Psychotropic Drug Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antipyretic Analgesic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antipyretic Analgesic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Circulatory System Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Circulatory System Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Peptic Ulcer Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Peptic Ulcer Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Osteoporosis Treatment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Osteoporosis Treatment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
South Korea | 259.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 12.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|